| Q73980565 | Additive cytotoxicity of different monoclonal antibody-cobra venom factor conjugates for human neuroblastoma cells |
| Q40842741 | Antibody transport in cultured tumor cell layers |
| Q40563987 | Antibody-targeted drugs for the therapy of cancer |
| Q30452831 | Complement-independent binding of microorganisms to primate erythrocytes in vitro by cross-linked monoclonal antibodies via complement receptor 1 |
| Q41047550 | Construction and characterisation of a functional CD19 specific single chain Fv fragment for immunotherapy of B lineage leukaemia and lymphoma |
| Q72049147 | Covalent binding of C3b to monoclonal antibodies selectively up-regulates heavy chain epitope recognition by T cells |
| Q33296224 | Designer gene delivery vectors: molecular engineering and evolution of adeno-associated viral vectors for enhanced gene transfer |
| Q41102000 | Development of a cell culture system to study antibody convection in tumors |
| Q41261974 | Diffusion of an anti-transferrin receptor antibody in cultured murine melanoma cell layers |
| Q58594217 | Enzymatic Transition States and Drug Design |
| Q40710606 | Long-circulating poly(ethylene glycol)-modified gelatin nanoparticles for intracellular delivery |
| Q40493015 | Macromolecular drug carrier systems in cancer chemotherapy: macromolecular prodrugs |
| Q71759737 | Monoclonal antibodies in cancer therapy |
| Q46149201 | Monoclonal antibody gene transfer. Implications for tumor-specific cell-mediated cytotoxicity |
| Q33718831 | Monoclonal antibody-directed cytotoxic therapy: potential in malignant diseases of aging |
| Q44899361 | PEGylation enhances tumor targeting of plasmid DNA by an artificial cationized protein with repeated RGD sequences, Pronectin |
| Q41540554 | Preclinical investigation of the antitumour effects of anti-CD19-idarubicin immunoconjugates |
| Q60300164 | Preclinical studies of monoclonal antibodies for intravesical radioimmunotherapy of human bladder cancer |
| Q33746856 | Receptor-mediated and enzyme-dependent targeting of cytotoxic anticancer drugs |
| Q72092560 | Reduction in the toxicity of aminopterin--monoclonal-antibody conjugates by leucovorin |
| Q57523324 | Rice cell culture as an alternative production system for functional diagnostic and therapeutic antibodies |
| Q33820623 | The use of bispecific antibodies in tumor cell and tumor vasculature directed immunotherapy. |
| Q36797027 | Toward cell-targeting gene therapy vectors: selection of cell-binding peptides from random peptide-presenting phage libraries |
| Q44356537 | Tumor targeting of gene expression through metal-coordinated conjugation with dextran |
| Q45872998 | Ultrasound enhancement of cationic lipid-mediated gene transfer to primary tumors following systemic administration |
| Q41702053 | Unconjugated antibodies for cancer therapy: lessons from the clinic. |